Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

The Philippines: a national survey

The Philippines has tremendous potential. It has one of the world’s fastest growing economies, and yet it doesn’t have many large healthcare service providers and it lacks a medical infrastructure sufficient to cope with all its residents’ needs. Healthcare Nova looks at the current market there, government policy, and how the private sector is changing.

Mixed investor sentiment in Turkey before referendum

With political uncertainty and concerns over the value of the Lira, investors in Turkey are facing a tricky decision. Should they stay or should they go? Healthcare Nova catches up with Turkish doctor Omer Karahan, a partner at healthcare consultancy Value Health.

MPIC’s hospital arm to expand in primary care

MPHHI, Filipino conglomerate MPIC’s hospital arm, is to launch a network of primary care centres. The group, whose net income surged 41% to P1.8bn (US$40m) in 2016, also wants to add a minimum of 10 hospitals to its network in the next five years, some of them from scratch – a departure from its usual buy-and-build growth strategy.

Hospital Corporation of China to launch Hong Kong IPO

Hospital management group Hospital Corporation of China (HCC) is looking to raise HK$500m (US$64m) through an IPO on the Hong Kong stock exchange this month. The proceeds will help fund HCC’s expansion in China.

IPOs galore in the UK, Sweden and Finland

A wave of IPOs in the Nordics and the UK look likely in healthcare services. Investec is planning to IPO fast-growth British teleradiology group Medica and East European outpatient player Medicover is supposed to be IPOing in the second quarter in Sweden. Meanwhile the two largest Finnish providers look set to IPO in 2017.

Leading French nursing homes – expanding in Europe, and retreating at home?

Leading French nursing home groups are looking to expand in Europe and pull back in France because of unfavourable domestic conditions. This is according to Stephane Pichon of Your Care Consult, who says that we should expect to see acquisitions – and possible sales – in the next six months.

Sales grow at Spire, but problems hurt margins

The CFO of the UK's second largest hospital group says the group's margins were negatively affected adversely by two problems last year - but it still saw rapid growth for other reasons.

Metropolis acquires pathology lab group

Indian diagnostics chain Metropolis has acquired Sanjeevani Pathology Labs in Rajkot, Gujarat, in an all-cash transaction. HBI speaks to Metropolis managing director Ameera Shah to find out more about the reasons behind the deal which concluded earlier this month, and the group's business strategy.

Find Us